May 29, 2025 a 12:38 pm
ISRG: Analysts Ratings - Intuitive Surgical, Inc.
Intuitive Surgical, Inc. is experiencing a diverse range of analyst ratings. With its innovative surgical systems like the da Vinci and Ion, it continues to lead in the minimally invasive medical technology space. However, recent shifts in analyst sentiment call for a closer look at how this might impact future performance.
Historical Stock Grades
| Rating | Count | Score |
|---|---|---|
| Strong Buy | 8 | |
| Buy | 14 | |
| Hold | 10 | |
| Sell | 1 | |
| Strong Sell | 1 |
Sentiment development
The review of historical data reveals significant patterns:
- The number of Strong Buys has remained constant over the past few months, indicating confidence in fundamental strengths.
- There was a slight increase in the Hold ratings, implying some caution or skepticism about immediate growth prospects.
- The Sell and Strong Sell ratings are minimal, suggesting limited bearish sentiment.
Percentage trends
The transformation in analyst sentiment is subtle but notable:
- The proportion of Buy and Strong Buy ratings has slightly decreased, indicating a potential revaluation.
- There is a mild increase in Hold ratings, hinting at increased caution regarding near-term performance.
- Recent months have shown a stabilization in the Sell and Strong Sell percentages, suggesting stable negative sentiment.
In the past year, there's been a slight shift from enthusiastic buys to more cautious holds.
Latest Analyst Recommendations
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-05-22 | Buy | Buy | Citigroup |
| 2025-04-24 | Overweight | Overweight | Barclays |
| 2025-04-23 | Buy | Buy | Truist Securities |
| 2025-04-23 | Overweight | Overweight | Piper Sandler |
| 2025-04-23 | Outperform | Outperform | Baird |
Analyst Recommendations with Change of Opinion
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2024-12-02 | Overweight | Equal Weight | Morgan Stanley |
| 2024-11-19 | Buy | Hold | Erste Group |
| 2024-08-02 | Buy | Neutral | Redburn Atlantic |
| 2022-02-02 | Buy | Neutral | UBS |
| 2022-02-01 | Buy | Neutral | UBS |
Interpretation
The market sentiment for Intuitive Surgical, Inc. reflects a mixture of confidence and caution. The persistence of Buy recommendations, balanced by an incremental rise in Hold ratings, points to an overall positive outlook with a degree of prudence. Few Sell recommendations reveal stable fundamental perceptions despite potential short-term uncertainties in the market.
The analysis suggests that while long-term confidence in the company's innovation and market position remains, short-term strategic shifts or market conditions may warrant closer attention.
Conclusion
The Intuitive Surgical, Inc. stock presents a balanced opportunity for investors, characterized by strong fundamental support from its robust medical technology offerings. While Buy recommendations dominate, the subtle rise in Hold stances suggests potential caution due to external market conditions or competitive dynamics. Given this backdrop, investors should consider both the promising innovations and the market-related risks when evaluating their positions in ISRG.